Target intelligence / Profile preview

Serum lipid (null)

Target
null
Molecular classification
Other (mixture: includes fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides)
01

Overview

Serum lipids refer to the collection of lipid molecules circulating in the bloodstream, including cholesterol, triglycerides, phospholipids, and lipoprotein-bound lipids. These molecules play essential roles in energy storage, cellular membrane structure, and signaling pathways, and act as precursors of steroid hormones and bile acids. Abnormalities in the concentrations and compositions of serum lipids are linked to major diseases, notably cardiovascular disease and metabolic disorders. The concentrations of specific serum lipid components (such as LDL, HDL, or triglycerides) are used in clinical diagnosis and monitoring, and are targeted by a variety of lipid-lowering drugs. Key facts: - "Serum lipids" is not a single molecular target, but rather a clinical collective term. - This group includes multiple molecular families with distinct roles and regulatory mechanisms. - Clinical measurement of serum lipids is a cornerstone of cardiovascular risk assessment, but it is not a molecular therapeutic "target" in the conventional sense. This entry is flagged as incorrect for use as a single molecular target.

Other names
Serum lipidsblood lipidscirculating lipids
02

Mechanism of action

Inhibition of cholesterol synthesis (statins) - Increased clearance of triglyceride-rich lipoproteins (fibrates) - Inhibition of intestinal absorption of cholesterol (ezetimibe) - Enhanced clearance of LDL via upregulation of LDL receptors (PCSK9 inhibitors)

03

Biological functions

Energy storageStructural component of cell membranesCell signalingPrecursor of hormones and bioactive mediators
04

Disease associations

Cardiovascular diseaseMetabolic syndromeDiabetesInflammationAtherosclerosisOther
05

Safety considerations

Risk of hepatotoxicity and myopathy (with statins)Altered absorption of fat-soluble vitamins (with bile acid sequestrants)Drug-drug interactions affecting lipid profile measurementsRisk of pancreatitis with severe hypertriglyceridemia
06

Interacting drugs

Statins (e.g., atorvastatin)

5 more in the full profile.

07

Biomarkers

Total cholesterolLDL cholesterolHDL cholesterolTriglyceridesLipoprotein(a)Apolipoproteins (ApoA1, ApoB)

Beyond the preview

Go deeper on Serum lipid (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum lipid (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call